Skip to main content
NYRADA INC. logo

NYRADA INC. — Investor Relations & Filings

Ticker · NYR ISIN · AU0000070195 ASX Professional, scientific and technical activities
Open in API
Filings indexed 472 across all filing types
Latest filing 2020-11-15 Capital/Financing Update
Country AU Australia
Listing ASX NYR

About NYRADA INC.

https://www.nyrada.com

Nyrada Inc. specializes in the development of novel small molecule therapeutic agents designed to address unmet needs in cardiovascular health and neuroprotection. The company’s lead programs include a cholesterol-lowering treatment and a neuroprotective treatment for brain injury. The cardiovascular program focuses on an oral PCSK9 inhibitor aimed at managing low-density lipoprotein (LDL) cholesterol levels as an alternative to injectable biologics. The neuroprotection program involves the development of NYR-BI03, a first-in-class small molecule designed to mitigate secondary brain damage following a stroke or traumatic brain injury by targeting canonical transient receptor potential (TRPC) ion channels. These efforts aim to provide effective, accessible pharmacological interventions for both chronic metabolic conditions and acute neurological trauma.

Recent filings

Filing Released Lang Actions
Release of Securities from Escrow 1 page 165.9KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 16 November 2020 from Nyrada Inc regarding the release of securities from escrow, referencing compliance with ASX Listing Rules. It details the number and class of securities to be released and mentions the company's intention to apply for quotation after the escrow period. There is no financial data, no detailed report, no management discussion, or earnings information. The document is brief (1713 characters) and serves as a regulatory announcement about securities escrow release, which is a capital structure update. This fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital securities status.
2020-11-15 English
Unlisted Convertible Note Options Expiring 30 November 2020 1
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 9 November 2020 from Nyrada Inc regarding the expiry of unlisted Convertible Note Options on 30 November 2020. It provides details about the options, exercise instructions, and escrow terms. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is informational about a specific capital instrument event (Convertible Note Options expiry and exercise). It does not contain a full financial report, earnings release, or management discussion. Given the content focuses on a capital instrument update and exercise instructions, it fits best under Capital/Financing Update (CAP). The document length is short (2324 characters), consistent with an announcement rather than a full report. Therefore, the classification is CAP with high confidence.
2020-11-08 English
2020 Annual General Meeting Reminder 1 page 191.8KB
AGM Information Classification · 95% confidence The document is a short announcement reminding shareholders of the upcoming Annual General Meeting (AGM) of Nyrada Inc, including details about the date, time, location, and arrangements due to COVID-19. It mentions that the Non-Executive Chair and CEO will provide a corporate update at the AGM. There is no detailed financial data, no full report, and no voting results. The document is under 5,000 characters and serves as a notice or reminder about the AGM event rather than the AGM materials themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or related to the AGM, including notices and reminders about the meeting.
2020-11-02 English
Notice of Annual General Meeting and Proxy Form 41 pages 2.9MB
AGM Information Classification · 95% confidence The document is a Notice of Annual General Meeting (AGM) for Nyrada Inc. It includes details about the AGM date, time, location (including virtual attendance), agenda items such as re-election of directors, remuneration report, proxy forms, and voting instructions. It explicitly states it is a Notice of Meeting and Proxy Statement related to the 2020 AGM. There is no full financial report or detailed financial statements included, only references to where the annual financial report can be viewed. The document is lengthy (15,000 characters) and contains detailed AGM materials, including resolutions and explanatory statements. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. It is not an Annual Report (10-K) or other financial report, nor is it a voting results announcement (DVA) or proxy solicitation (PSI) alone. Therefore, the correct classification is AGM-R with high confidence.
2020-10-18 English
Letter to Shareholders and Proxy Form in relation to AGM 9 pages 706.6KB
AGM Information Classification · 100% confidence The document is dated 19 October 2020 and relates to the Annual General Meeting (AGM) of Nyrada Inc. It includes a letter to shareholders, proxy form, details about the meeting date, venue (virtual due to COVID-19), voting instructions, resolutions to be voted on, and other procedural information. The content is focused on providing information and materials related to the AGM rather than reporting financial results or other types of filings. The document is lengthy (15,000 characters) and contains detailed AGM-related materials, not just an announcement or notice of a report. Therefore, it fits the category of AGM Information (AGM-R).
2020-10-18 English
Nyrada Quarterly Activities Report & Appendix 4C 10 pages 452.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Nyrada Quarterly Activities Report & Appendix 4C' and is dated 13 October 2020. It provides detailed updates on the company's preclinical drug development programs, corporate and financial summaries, board changes, and cash flow information for the quarter ending 30 September 2020. The inclusion of the Appendix 4C, which is a quarterly cash flow report required by the ASX Listing Rules, confirms this is a quarterly report. The document contains substantive financial data, operational updates, and management commentary typical of an Interim / Quarterly Report. It is not merely an announcement or a brief summary but a comprehensive report for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2020
2020-10-12 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.